JSLL · NSE
Jeena Sikho Lifecare Limited
₹510.4
+4.00% (+₹19.65)
Prev. close
₹490.75
Volume
3,41,598
Delivery %
56.6%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited trades in ayurvedic products in India and internationally. It operates through Ayurvedic products/medicine, Ayurvedic healthcare services, and others segments. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Mr. Manish Grover
Headquarters
Zirakpur
Employees
4,299
Website
jeenasikho.comExchange
View on NSE ↗Key stats
Market cap
₹6,344.31 Cr
P/E ratio (TTM)
26.9
Dividend yield
0.92%
EPS (TTM)
₹18.99
Beta (1Y · daily vs NIFTY 50)
1.23
Beta (5Y · monthly vs NIFTY 50)
0.62
Shares float
3.97 Cr
EPS · quarter ended Jun 2026
₹5.29
Financial Performance
01 · Financials
FY22 growth needs FY21 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ₹146.55 Cr | ₹203.90 Cr | ₹324.41 Cr | ₹469.07 Cr | ₹801.36 Cr | |
| EBITDA | ₹19.54 Cr | ₹48.20 Cr | ₹99.09 Cr | ₹146.87 Cr | ₹357.92 Cr |
| ₹11.00 Cr | ₹33.74 Cr | ₹69.21 Cr | ₹79.94 Cr | ₹221.85 Cr | |
| Diluted EPS | ₹11.11 | ₹2.74 | ₹5.57 | ₹6.42 | ₹17.81 |
Total expenses (as filed), Employee benefit expense, Other expenses, Other income have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ₹62.00 Cr | ₹151.00 Cr | ₹272.22 Cr | ₹419.00 Cr | ₹674.00 Cr | |
| — | ₹80.80 L | ₹57.67 Cr | ₹116.94 Cr | ₹127.30 Cr | |
| Stockholders' equity | ₹36.00 Cr | ₹126.00 Cr | ₹185.93 Cr | ₹256.00 Cr | ₹467.00 Cr |
Trade receivables, Cash & equivalents, CWIP, Others, Total debt have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ₹16.00 Cr | ₹15.00 Cr | ₹36.69 Cr | ₹84.00 Cr | ₹254.00 Cr | |
| Investing cash flow | ₹-18.22 Cr | ₹-57.23 Cr | ₹-18.05 Cr | ₹-64.48 Cr | ₹-201.68 Cr |
| ₹-4.51 Cr | ₹48.00 Cr | ₹-3.44 Cr | ₹-22.45 Cr | ₹-58.68 Cr | |
| Capital expenditure | ₹-17.08 Cr | ₹-38.20 Cr | ₹-15.54 Cr | ₹-42.33 Cr | ₹-34.05 Cr |
| End cash position | ₹2.59 Cr | ₹10.12 Cr | ₹25.31 Cr | ₹22.98 Cr | ₹16.37 Cr |
Debt issued, Debt repaid, Dividends paid have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Apr 22–Sep 22(2Q) | Mar 23 | Sep 23–Mar 24(3Q) | Sep 24 | Mar 25–Jun 25(2Q) | Sep 25 | Dec 25–Jun 26(3Q) |
|---|---|---|---|---|---|---|---|
| Promoter | 65.89% | 66.20% | 67.91% | 65.84% | 63.53% | 63.61% | 63.62% |
| Public | 34.11% | 33.80% | 32.09% | 34.16% | 36.47% | 36.39% | 36.38% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| Jeena Sikho Lifecare Limited | ₹6,100.06 Cr | ₹510.4 | 25.8 | 13.06 | 47.5% | 0.27 | +70.4% | -37.8% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Concall transcripts
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
3 indices
Weight is a free-float market-cap-share estimate from NSE’s live index data, not NSE’s own published (and sometimes capped) index weight. Indices without a live weight feed are listed without one, in alphabetical order after the weighted ones.